{"database": "lobbying", "table": "lobbying_activities", "rows": [[2308449, "4544c73b-aea9-455b-925a-23969f8a466c", "Q2", "ROCK & ASSOCIATES", 33545, "VETERINARY PHARMACIES OF AMERICA, INC.", 2019, "second_quarter", "PHA", "H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.", "HOUSE OF REPRESENTATIVES,SENATE", 11250, null, 0, 0, "2019-07-17T17:41:48.530000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2308449"], "units": {}, "query_ms": 52.74189403280616, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}